INN: Heparin sodium
– solution for intravenous and subcutaneous administration 5000 ME/ml 5 ml vial 5 units per pack
Included in the List of Vital and Essential Drugs
Registration number: R N002077/01
Pharmacotherapeutic group: direct-action anticoagulant.
Indications for use:
♦ thrombosis, thromboembolism (prevention and treatment);
♦ prevention of blood clotting (in cardiovascular surgery);
♦ coronary thrombosis;
♦ disseminated intravascular coagulation;
♦ post-operative period in patients with a history of thromboembolic diseases;
♦ inhibition of blood clotting during extracorporeal circulation.
Shelf life: 4 years.